Business

Stocks in news: SBI, Titan, Hyundai, BSE, Torrent Pharma, Axis Bank


Markets traded volatile on Thursday and ended almost unchanged amid favourable cues. Despite the favourable cues, analysts say the Nifty continues to face a lack of momentum on the upside due to the resistance posed by key moving averages (100 and 200 DEMA) in the 24,550-24,750 zone.

In today’s trade, shares of SBI, Titan, Hyundai, BSE, Torrent Pharma, Axis Bank among others will be in focus due to various news developments.

SBI, Titan, Hyundai, Bank of Baroda, Tata Consumer, Swiggy, MCX, Adani Gas, Kalyan Jewellers, Urban Company
Shares of SBI, Titan, Hyundai, Bank of Baroda, Tata Consumer, Swiggy, MCX, Adani Gas, Kalyan Jewellers and Urban Company will be in focus as the companies will be announce their fourth quarter results.Britannia Industries
FMCG company Britannia Industries reported 21% year-on-year (YoY) growth in its consolidated net profit at Rs 678 crore in the fourth quarter, compared with Rs 560 crore in the year-ago quarter. The company’s board has also recommended a final dividend of Rs 90.5 per share.


BSE
India’s oldest exchange BSE reported a consolidated net profit at Rs 797 crore in the March-ended quarter versus Rs 494 crore in the year ago period, implying a 61% surge. The profit after tax (PAT) attributable to the shareholders of the holding company.
Bharat Forge
Bharat Forge reported a consolidated net profit at Rs 233 crore in the March-ended quarter versus Rs 283 crore in the year ago period, implying a 17% fall. The components manufacturer posted a revenue growth of 18% to Rs 4,528 crore in Q4FY26 was versus Rs 3,853 crore posted by the company in the corresponding quarter of the previous financial year.
Dabur
FMCG major Dabur India reported a consolidated net profit at Rs 369 crore in the March-ended quarter versus Rs 320 crore in the year ago period, implying a 15% uptick. The profit after tax (PAT) is attributable to the owners of the holding company.

Torrent Pharma
Ahmedabad-based drug maker Torrent Pharma has taken a significant early lead in the generic semaglutide market, grabbing a nearly 38% share within a month of launch, as per industry data accessed by ET. Over a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of Novo Nordisk’s patent for the innovator molecule in end-March. They generated about Rs 44 crore in generic semaglutide sales in April.

Emami
Emami will acquire a 60% stake in IncNut Digital, owner of direct-to-consumer beauty and personal care brands Vedix and SkinKraft, for ₹321 crore in an all-cash deal. The Kolkata-based FMCG company will acquire the remaining 40% stake over the next four-and-a-half years in two tranches, with the valuation linked to future performance.

IndiGo
India’s domestic airline IndiGo will start operations from the newly inaugurated Noida International Airport in Jewar, Uttar Pradesh, on 15 June 2026, said the airline’s release on Thursday.

Axis Bank
Axis Bank, India’s third-largest private lender, has signed a $500 million offshore loan with Mitsubishi UFJ Financial Group Inc, ET reported, underscoring rising demand for bank credit.



Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top